You Position: Home > Paper
Progress on targeting TRAIL's receptor as antitumor strategy
( views:39, downloads:0 )
- Author:
- No author available
- Journal Title:
- ACTA PHARMACEUTICA SINICA
- Issue:
- 12
- DOI:
- 10.3321/j.issn:0513-4870.2009.12.004
- Key Word:
- TRAIL;死亡受体;细胞凋亡;抗肿瘤作用;TRAIL;death receptor;apoptosis;antitumor activity
Abstract： There exist two major apoptotic signaling pathways:the intrinsic mitochondria-mediated pathway,and the extrinsic death receptor-induced pathway.TNF-related apoptosis-inducing ligand(TRAIL),which is the ligand for death receptor 4(DR4)and death receptor 5(DR5)and induces apoptosis by ligation with DR4 or DR5. We review the characteristic of TRAIL and its receptors,the mechanism of apoptosis induced by TRAIL,the distribution of death receptors in cancer,and applications and prospects of TRAIL signaling pathway in the treatment of cancer.
- [1]侯琦.Staurosporine诱导人乳腺癌MCF7/GFP-Bax非受体依赖途径的细胞凋亡对Bax自胞浆至线粒体转移定位的影响[J].2008,(4).
- [2]时平,陈蔚文,胡晓燕,等.姜黄素上调前列腺癌细胞LNCaP中maspin基因的表达[J].2006,(12).
- [3]Aggarwal BB,Reuter S,Diederich M,etc.Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells.[J].2008,76(11).
- [4]Pribill I,Haller G,Roessler M,etc.Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer.[J].2005,3(6).
- [5]Lalaoui N,Solary E,Schneider P,etc.Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2[J].2006,26(19).
- [6]S R, Wiley,K, Schooley,P J, Smolak,etc.Identification and characterization of a new member of the TNF family that induces apoptosis.[J].1995,3(6).
- [7]Kleibeuker JH,Hollema H,de Vries EG,etc.Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas.[J].2003,200(3).
- [8]Ashkenazi A,LeBlanc HN.Apo2L/TRAIL and its death and decoy receptors.[J].2003,10(1).
- [9]Atkins GJ,Labrinidis A,Hay S,etc.Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy.[J].2003,89(1).
- [10]Chen S,Liu X,Sun SY,etc.CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing l[J].2007,72(5).
- [11]Bouralexis S,Findlay DM,Evdokiou A.Death to the bad guys: Targeting cancer via Apo2L/TRAIL[J].2005,10(1).
- [12]El Zawahry A,White SJ,Lu P,etc.In vitro efficacy of AdTRAIL gene therapy of bladder cancer is enhanced by trichostatin A-mediated restoration of CAR expression and downregulation of cFLIP and Bcl-XL.[J].2006,13(3).
- [13]Ricky W. Johnstone,Mark J. Smyth,Aiisa J. Frew.The TRAIL apoptotic pathway in cancer onset, progression and therapy[J].2008,8(10).
- [14]Yoo J,Lee YJ,Park SS.Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells.[J].2008,104(5).
- [15]Ford H,Behbakht K,Thorburn A.TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them.[J].2008,11(1).
- [16]Smyth MJ,Takeda K,Cretney E.Cancer: novel therapeutic strategies that exploit the TNF-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway.[J].2007,39(2).
- [17]Clayman GL,Guan B,Sun SY,etc.Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene.[J].2001,188(1).
- [18]Smyth MJ,Uno T,Okumura K,etc.Eradication of established tumors in mice by a combination antibody-based therapy.[J].2006,12(6).